MENU

ANAB AnaptysBio Forecast, Technical & Fundamental Analysis

a provider of therapeutic antibodies for inflammation and immuno-oncology

Industry Biotechnology
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ANAB is expected to report earnings to rise 42.98% to -162 cents per share on February 27

AnaptysBio ANAB Stock Earnings Reports
Q4'24
Est.
$-1.63
Q3'24
Beat
by $0.56
Q2'24
Missed
by $0.67
Q1'24
Missed
by $0.05
Q4'23
Beat
by $0.04
The last earnings report on November 05 showed earnings per share of -113 cents, beating the estimate of -170 cents. With 1.04M shares outstanding, the current market capitalization sits at 486.55M.
A.I. Advisor
published General Information

General Information

a provider of therapeutic antibodies for inflammation and immuno-oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10770 Wateridge Circle
Phone
+1 858 362-6295
Employees
117
Web
https://www.anaptysbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA463.0226.79
+6.14%
Tesla
GME29.441.45
+5.18%
GameStop Corp
BTC.X106029.7200001731.023400
+1.66%
Bitcoin cryptocurrency
AAPL251.042.91
+1.17%
Apple
SPY606.792.58
+0.43%
SPDR® S&P 500® ETF Trust

ANAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with ADCT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then ADCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANAB
1D Price
Change %
ANAB100%
+6.80%
ADCT - ANAB
40%
Loosely correlated
+5.82%
HRMY - ANAB
40%
Loosely correlated
+2.07%
SAGE - ANAB
38%
Loosely correlated
-0.74%
SLRN - ANAB
36%
Loosely correlated
+4.33%
AURA - ANAB
35%
Loosely correlated
+5.71%
More